2 news items
Celularity Says That Its Expected Net Sales For Q1 2024 Are Trending Ahead Of The Expectations It Announced In February For Its Advanced Biomaterial Products And Biobanking Businesses; Implements Planned 2024 SG&A Reductions And Manufacturing Ramp For Advanced Biomaterial Products
CELU
15 Apr 24
payable in 2024."This action by Celularity's leadership team will bolster our ability to invest in expanding production of our advanced
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
CELU
15 Apr 24
payable in 2024. "This action by Celularity's leadership team will bolster our ability to invest in expanding production
- Prev
- 1
- Next